Home 2018
Archives
AAN: New Drug May Help Infants With Spinal Muscular Atrophy
RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose
AAN: Cerliponase Alfa Beneficial for Form of Batten’s Disease
Reduced decline in motor, language function in children with CLN2 compared with historical controls
Drug-Related Endocarditis Cases Up From 2007 to 2015
Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use
Study Finds 31 Percent Use No Opioids After Surgery
At discharge, 92.2 percent of patients received an opioid prescription; nearly 63 percent unused
Eight Factors Predict Pain After Spine Surgery
Post-op pain strongly linked to number of classes of non-opioid analgesics used, remifentanil use
AAN: Neuromodulation Therapy Gives Relief From Hand Tremor
Non-invasive neuromodulation therapy using a custom stimulation pattern safe for essential tremor
Less Pain Post TKA With Addition of Peripheral Nerve Blocks
Lower numeric rating scale pain scores on ambulation on postoperative days zero, one, and two
AAN: New Drug May Help Infants With Spinal Muscular Atrophy
RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose
AAN: Erenumab Shows Promise for Hard-to-Treat Migraine
Higher proportion of patients achieved a ≥50 percent reduction in mean monthly migraine days
Adjuvant Pembrolizumab Beneficial in Stage III Melanoma
Pembrolizumab linked to significantly longer recurrence-free survival at 15-month follow-up
